POULTON JEFFREY V. (Chief Financial Officer) exercised options at ALNYLAM PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 3/2/2026ACC: 0001735276-26-000040
Officer· Chief Financial Officer
Since Aug 2019
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.91K acquired · 1.91K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.91K
Price / share
—
Trade value
—
% of position
3.2%
2/27/2026
59.80K→61.71K
Total
Net shares
+1.91K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2026 | M · Option Exercise | +1.91K | — | — | 3.2% | 59.80K | 61.71K |
| Total | +1.91K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
1.91K shares
Shares
−1.91K
Strike price
Held after
0.00
Exercisable
—
2/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock1.91K shares | 2/27/2026 | M · Option Exercise | −1.91K | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned57.00
Total
57.00 indirect57.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 57.00 | Indirect |
| Total | 57.00 | 57.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported